RALEIGH, N.C.--(BUSINESS WIRE)-- LipoScience, Inc., a diagnostic company that is advancing patient care through high value proprietary tests based on nuclear magnetic resonance (NMR) technology, today announced it has appointed Thomas Clement as Vice President, Regulatory and Quality Affairs. In this role, Mr. Clement will develop and implement regulatory strategies needed to support the approvals and clearances of the products coming through the development pipeline and support the continual activities required within the organization to maintain an effective and compliant quality system.
